155 related articles for article (PubMed ID: 27407167)
1. Nonadherence to Oral Medications for Chronic Conditions in Breast Cancer Survivors.
Yang J; Neugut AI; Wright JD; Accordino M; Hershman DL
J Oncol Pract; 2016 Aug; 12(8):e800-9. PubMed ID: 27407167
[TBL] [Abstract][Full Text] [Related]
2. Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer.
Neugut AI; Zhong X; Wright JD; Accordino M; Yang J; Hershman DL
JAMA Oncol; 2016 Oct; 2(10):1326-1332. PubMed ID: 27281650
[TBL] [Abstract][Full Text] [Related]
3. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
Calip GS; Elmore JG; Boudreau DM
Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
[TBL] [Abstract][Full Text] [Related]
4. Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events.
Hershman DL; Accordino MK; Shen S; Buono D; Crew KD; Kalinsky K; Trivedi MS; Hur C; Hu J; Unger JM; Wright JD
Cancer; 2020 Apr; 126(7):1541-1549. PubMed ID: 31913500
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A 6-Year Propensity Score-Matched Cohort Study.
Zhou J; Han J; Nutescu EA; Patel PR; Sweiss K; Calip GS
Pharmacotherapy; 2019 Jan; 39(1):55-66. PubMed ID: 30485471
[TBL] [Abstract][Full Text] [Related]
6. The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study.
Han E; Suh DC; Lee SM; Jang S
Res Social Adm Pharm; 2014; 10(6):e87-e98. PubMed ID: 25088545
[TBL] [Abstract][Full Text] [Related]
7. Previously undiagnosed risk factors and medication nonadherence are prevalent in young adults with first-ever stroke.
Sung SF; Lai EC; Wu DP; Hsieh CY
Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1458-1464. PubMed ID: 28691203
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer.
Calip GS; Xing S; Jun DH; Lee WJ; Hoskins KF; Ko NY
J Oncol Pract; 2017 May; 13(5):e451-e462. PubMed ID: 28287854
[TBL] [Abstract][Full Text] [Related]
9. Primary non-adherence in Portugal: findings and implications.
da Costa FA; Pedro AR; Teixeira I; Bragança F; da Silva JA; Cabrita J
Int J Clin Pharm; 2015 Aug; 37(4):626-35. PubMed ID: 25832675
[TBL] [Abstract][Full Text] [Related]
10. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
[TBL] [Abstract][Full Text] [Related]
11. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.
Calip GS; Hubbard RA; Stergachis A; Malone KE; Gralow JR; Boudreau DM
Pharmacoepidemiol Drug Saf; 2015 Jan; 24(1):75-85. PubMed ID: 24923811
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension.
Marcum ZA; Zheng Y; Perera S; Strotmeyer E; Newman AB; Simonsick EM; Shorr RI; Bauer DC; Donohue JM; Hanlon JT;
Res Social Adm Pharm; 2013; 9(6):817-27. PubMed ID: 23291338
[TBL] [Abstract][Full Text] [Related]
13. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines.
Manteuffel M; Williams S; Chen W; Verbrugge RR; Pittman DG; Steinkellner A
J Womens Health (Larchmt); 2014 Feb; 23(2):112-9. PubMed ID: 24206025
[TBL] [Abstract][Full Text] [Related]
14. Patient characteristics associated with medication adherence.
Rolnick SJ; Pawloski PA; Hedblom BD; Asche SE; Bruzek RJ
Clin Med Res; 2013 Jun; 11(2):54-65. PubMed ID: 23580788
[TBL] [Abstract][Full Text] [Related]
15. Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation.
Melzer AC; Uman J; Au DH
Ann Am Thorac Soc; 2015 Jun; 12(6):831-7. PubMed ID: 25849224
[TBL] [Abstract][Full Text] [Related]
16. Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
Brier MJ; Chambless DL; Gross R; Chen J; Mao JJ
Cancer; 2017 Jan; 123(1):169-176. PubMed ID: 27570979
[TBL] [Abstract][Full Text] [Related]
17. Health Behaviors and Medication Adherence in Elderly Patients.
Han E; Sohn HS; Lee JY; Jang S
Am J Health Promot; 2017 Jul; 31(4):278-286. PubMed ID: 26730557
[TBL] [Abstract][Full Text] [Related]
18. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
Offord S; Lin J; Mirski D; Wong B
Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
[TBL] [Abstract][Full Text] [Related]
19. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.
Zhang Y; Lave JR; Donohue JM; Fischer MA; Chernew ME; Newhouse JP
Med Care; 2010 May; 48(5):409-17. PubMed ID: 20393360
[TBL] [Abstract][Full Text] [Related]
20. Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study.
Wells KJ; Pan TM; Vázquez-Otero C; Ung D; Ustjanauskas AE; Muñoz D; Laronga C; Roetzheim RG; Goldenstein M; Carrizosa C; Nuhaily S; Johnson K; Norton M; Sims E; Quinn GP
Support Care Cancer; 2016 Oct; 24(10):4123-30. PubMed ID: 27146492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
